Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

Verona Pharma (NASDAQ:VRNA)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Verona Pharma Charts.

Verona Pharma (NASDAQ:VRNA)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Verona Pharma Charts.

Verona Pharma Plc News

Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update
Thursday 13 February 2025 (4 days ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 4 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 7 January 2025 (1 month ago) • Edgar (US Regulatory)

Verona Pharma Reports Strong Ohtuvayre™ Launch and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Highlights
Tuesday 7 January 2025 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 26 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Monday 25 November 2024 (3 months ago) • Edgar (US Regulatory)

Verona Pharma Announces December 2024 Investor Conference Participation
Tuesday 19 November 2024 (3 months ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 7 November 2024 (3 months ago) • Edgar (US Regulatory)

Verona Pharma to Present at Jefferies London Healthcare Conference
Tuesday 5 November 2024 (3 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Monday 4 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 4 November 2024 (3 months ago) • Edgar (US Regulatory)

More Verona Pharma Plc News Articles

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions